✦ LIBER ✦

HYPOTHYROIDISM AND GOITRE DURING INTERLEUKIN-2 THERAPY WITHOUT LAK CELLS

✍ Scribed by Liessum, P.A.Van; De Mulder, P.H.M.; Mattijssen, E.J.M.; Corstens, F.H.M.; Wagener, D.J.Th

Book ID: 121980438
Publisher: The Lancet
Year: 1989
Tongue: English
Weight: 151 KB
Volume: 333
Category: Article
ISSN: 0140-6736
DOI: 10.1016/S0140-6736(89)91244-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Multiple organ failure during interleuki

Multiple organ failure during interleukin-2 administration and LAK cells infusion

✍ J. P. Sculier; D. Bron; J. Verboven; J. Klastersky 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 185 KB

Adoptive immunotherapy is a new promising treatment for cancer but is associated with severe toxicity mainly related to a capillary leak syndrome. We report the case of a patient with metastatic hypernephroma, who had many complications such as coma, renal failure, pulmonary edema, life-threatening

Interleukin-2 with and without LAK cells

Interleukin-2 with and without LAK cells in metastatic renal cell carcinoma: the Lyon first-year experience in 20 patients

✍ Philip, T.; Mercatello, A.; Negrier, S.; Philip, I.; Rebattu, P.; Kaemmerlin, P. 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 934 KB

Human interleukin 4 regulates the phenot

Human interleukin 4 regulates the phenotype of lymphocytes generated during mixed lymphocyte culture and inhibits the IL-2-induced development of LAK function in normal and leukaemic cells

✍ Boquan Jin; Angel F. Lopez; Steven Gillis; Christopher A. Juttner; Mathew A. Vad 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 681 KB

Interleukin-1α and soluble interleukin-2

Interleukin-1α and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSF

✍ Gautier, Véronique; Pujol, Jean-Louis; Michel, François-Bernard 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 502 KB

Interleukin-1α and soluble interleukin-2

Interleukin-1α and soluble interleukin-2 receptor during small cell lung cancer chemotherapy: Comparison of high chemotherapy dose with rhGM-CSF and standard chemotherapy dose without rhGM-CSF

📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 134 KB

Serum Levels of Soluble Cell Adhesion Mo

Serum Levels of Soluble Cell Adhesion Molecules (ICAM-1, VCAM-1, E-Selectin) and of Cytokine TNF-α Increase during Interleukin-2 Therapy

✍ Claudio Fortis; Laura Galli; Giuseppe Consogno; Giovanni Citterio; Paola Matteuc 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 363 KB